| Echo Spring Love, OTR/L | |
|
21015 E Creekside Dr, Queen Creek, AZ 85142-5044 | |
| (480) 766-3317 | |
| Not Available |
| Full Name | Echo Spring Love |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 21015 E Creekside Dr, Queen Creek, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861852790 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 6492 (Arizona) | Primary |
| Provider Name | Solace Pediatric Healthcare Therapy Services Az, Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1669533105 PECOS PAC ID: 2163784299 Enrollment ID: O20180329000661 |
News Archive
In the face of a flu epidemic, a one-size fits all vaccine strategy won't be effective, a York University study has found. Instead, strategies need to change significantly depending on the characteristics of each region in Canada and how easily the particular flu strain spreads.
India Business Council supported ‘Coalition for Healthy India' released the findings of its report on "The Value of Incremental Pharmaceutical Innovation: Benefits for Indian Patients and Indian Business". The report highlights and substantiates the impact of restrictive policies in India, with respect to medical and pharmaceutical innovation.
Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical results presented at the AACR-IASLC (American Academy of Cancer Research – International Association for the Study of Lung Cancer) Joint Conference based on work done at Synta and at the Dana-Farber Cancer Institute in Boston showed that STA-9090, a potent, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated potent activity against 100% of all non-small cell lung cancer cell lines tested, including those with EGFR, HER2 or KRAS mutations including the EGFR T790 mutation that is present in roughly 50% of cases of erlotinib or gefitinib resistance.
AARP, the seniors' lobby, has shed as many as 60,000 members in two months over its implicit support for health reform that some members say could lead to Medicare cuts, USA Today reports. The group will launch a campaign next week in hopes of regaining ground with seniors and reestablishing a politically neutral image.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Echo Spring Love, OTR/L 21015 E Creekside Dr, Queen Creek, AZ 85142-5044 Ph: (480) 766-3317 | Echo Spring Love, OTR/L 21015 E Creekside Dr, Queen Creek, AZ 85142-5044 Ph: (480) 766-3317 |
News Archive
In the face of a flu epidemic, a one-size fits all vaccine strategy won't be effective, a York University study has found. Instead, strategies need to change significantly depending on the characteristics of each region in Canada and how easily the particular flu strain spreads.
India Business Council supported ‘Coalition for Healthy India' released the findings of its report on "The Value of Incremental Pharmaceutical Innovation: Benefits for Indian Patients and Indian Business". The report highlights and substantiates the impact of restrictive policies in India, with respect to medical and pharmaceutical innovation.
Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical results presented at the AACR-IASLC (American Academy of Cancer Research – International Association for the Study of Lung Cancer) Joint Conference based on work done at Synta and at the Dana-Farber Cancer Institute in Boston showed that STA-9090, a potent, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated potent activity against 100% of all non-small cell lung cancer cell lines tested, including those with EGFR, HER2 or KRAS mutations including the EGFR T790 mutation that is present in roughly 50% of cases of erlotinib or gefitinib resistance.
AARP, the seniors' lobby, has shed as many as 60,000 members in two months over its implicit support for health reform that some members say could lead to Medicare cuts, USA Today reports. The group will launch a campaign next week in hopes of regaining ground with seniors and reestablishing a politically neutral image.
› Verified 2 days ago
Cassie Maddigan, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 43507 N Ironwood Dr, Queen Creek, AZ 85140 Phone: 805-657-6126 | |
Connected Kids Pediatric Therapy, Llc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 20588 S Ellsworth Loop Rd Apt 3125, Queen Creek, AZ 85142 Phone: 602-341-3770 Fax: 602-560-0504 | |
Mrs. Kim T Betancourt, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 18724 E Swan Dr, Queen Creek, AZ 85142 Phone: 347-992-4793 | |
Mr. Brendan Darell Cluff, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2018 E Paso Fino Dr, Queen Creek, AZ 85240 Phone: 480-325-0838 | |
Abby Mcneil, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 31437 N Desert Star Dr, Queen Creek, AZ 85243 Phone: 602-330-6697 | |
Anastasia Cuenco, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 20996 E Canary Way, Queen Creek, AZ 85142 Phone: 224-619-6322 | |
Beth Duyck, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 21311 E Orchard Ln, Queen Creek, AZ 85242 Phone: 480-220-3347 |